Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Cohort Study

Shigeo Shimose(Kurume University), Takuji Torimura(Omuta hospital), Hironori Koga(Kurume University), Kazunori Noguchi(Omuta hospital), Kentaro Miyazaki(Osaka International University), Hideya Suga(Yanagawa Rehabilitation Hospital), Masatoshi Tanaka(Fukushima Medical University), Hideki Iwamoto, Takashi Niizeki(Kurume University), Takumi Kawaguchi(Kurume University), Miki Ono(Yanagawa Rehabilitation Hospital), Taizo Yamaguchi, Yoshinori Yokokura(ShinKokura Hospital), Tomotake Shirono(Kurume University), Shusuke Okamura(Kurume University), Masahito Nakano(Kurume University)
Nutrients
April 13, 2020
10.3390/nu12041076
Cited by 47

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504